Pre-earnings options volume in Hologic is 1.5x normal with calls leading puts 15:2. Implied volatility suggests the market is anticipating a move near 3.5%, or $2.94, after results are released. Median move over the past eight quarters is 2.4%.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on HOLX:
- Hologic price target raised to $90 from $77 at Mizuho
- Hologic price target raised to $80 from $75 at Wells Fargo
- Hologic reports preliminary Q1 revenue $1.074B, consensus $966.37M
- Hologic initiated with a Sector Perform at RBC Capital
- Hologic’s new data identifies patients benefiting from endocrine therapy